Gregory J Beal, Jr

Title: Gregory J Beal, Jr: Innovator in Genetic Research

Introduction

Gregory J Beal, Jr is a notable inventor based in New Market, MD (US). He has made significant contributions to the field of genetic research, particularly in the study of the ETS2 repressor factor (ERF). With a total of 2 patents, his work has implications for cancer research and treatment.

Latest Patents

Beal's latest patents focus on the ERF gene and its encoded products. The first patent, titled "ETS2 repressor factor (ERF)," relates to DNA sequences encoding ERF and AERF, as well as polypeptides and chimeric molecules derived from these sequences. This invention aims to reduce tumorigenicity in tumor cells. The second patent, "ETS2 repressor factor (ERF) genetic locus and its products," shares similar themes, emphasizing the importance of ERF in genetic research and its potential applications in oncology.

Career Highlights

Throughout his career, Gregory J Beal, Jr has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to groundbreaking research in genetics.

Collaborations

Beal has collaborated with notable colleagues such as George J Mavrothalassitis and Donald G Blair. These partnerships have furthered his research and expanded the impact of his inventions in the scientific community.

Conclusion

Gregory J Beal, Jr is a prominent figure in genetic research, with a focus on the ETS2 repressor factor. His patents and collaborations highlight his commitment to advancing knowledge in the field and improving cancer treatment options.